Physician profile

Zia U Khan

Cardiovascular Disease · Las Vegas, NV

NPI 1386633543

$10,661.96

in general payments reported to CMS, 2019-2025

47 companies · $2,338 in 2025

The $2,338 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,636.41
Education$482.23

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Actelion Pharmaceuticals US, INC. $2,523.89 2019-2025 Uptravi, Opsumit, Opsynvi
Boston Scientific Corporation $1,617.13 2019-2025 General - Atherectomy, Jetstream Sc, Varithena Administration Pack
Medtronic, INC. $683.26 2021-2025 Symplicity G3, Reveal Linq
Abbott Laboratories $677.42 2019-2025 Jot Dx, Mitraclip, Diamondback Peripheral
Merck Sharp & Dohme LLC $610.71 2022-2025 Winrevair, Verquvo, Capvaxive
Janssen Pharmaceuticals, INC $418.58 2019-2024 Xarelto
Cardiovascular Systems INC. $402.04 2019-2022
Amgen INC. $324.39 2019-2025 Repatha, Repatha
Organogenesis INC. $306.18 2023 Puraply
Siemens Medical Solutions USA, INC. $275.63 2025 Naeotom Alpha, Biograph Mct X-4r, Biograph Horizon-3r
Novartis Pharmaceuticals Corporation $243.60 2023-2025
Pfizer INC. $243.30 2022-2025
Abiomed $207.93 2019-2023 Impella
Philips North America LLC $180.62 2022-2025 Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $165.71 2022-2025 Lifevest
Show all 47 companies
CompanyGeneral paymentsYearsTop products
Cvrx, INC. $155.66 2023-2025 Barostim Neo System
Teleflex LLC $150.00 2024 Spectre
Novo Nordisk INC $143.87 2022-2025 Wegovy, Ozempic, Rybelsus
Nevro Corp. $125.98 2024 Senza
Kiniksa Pharmaceuticals, LTD. $120.38 2022-2023 Arcalyst
Astrazeneca Pharmaceuticals LP $120.05 2019-2023 Farxiga
E.R. Squibb & Sons, L.L.C. $94.37 2022-2025 Camzyos
Irhythm Technologies, INC. $92.94 2022-2024 Zio Xt Patch, Zio Monitor
Bard Peripheral Vascular, INC. $87.40 2024-2025 Venclose Maven Catheter, Set Aspirex S 10f 110cm
Intuitive Surgical, INC. $60.71 2024
Alnylam Pharmaceuticals INC. $55.88 2025 Amvuttra
Bayer Healthcare Pharmaceuticals INC. $51.85 2023-2025
Becton, Dickinson and Company $47.28 2023-2025 Rotarexs 6 F X 135 Cm, Atlas
Medline Industries LP $47.07 2020-2021
Edwards Lifesciences Corporation $45.49 2021-2025
Shockwave Medical, INC $37.67 2021-2024 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Biotronik INC. $37.30 2019
Medtronic Vascular, INC. $33.98 2020
Terumo Medical Corporation $28.43 2022
Inari Medical, INC. $26.86 2021
Penumbra, INC. $26.13 2020
Kiniksa Pharmaceuticals International, Plc $24.20 2024 Arcalyst
United Therapeutics Corporation $22.88 2024 Tyvaso
Regeneron Healthcare Solutions, INC. $22.41 2024 Evkeeza
Asahi Intecc USA, INC. $21.08 2024 Peripheral Vascular
Innovation Technologies INC $19.65 2025 Irrisept
Baxter Healthcare $18.84 2024 Hillrom - Carnation Ambulatory Monitor
Inspire Medical Systems, INC. $15.69 2025 Inspire
Chiesi USA, INC. $12.74 2023 Kengreal
Kowa Pharmaceuticals America, INC. $11.79 2022
Bardy Diagnostics, INC. $11.64 2022
Medicomp INC $11.35 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Zia U Khan

$10,661.96

in general payments reported 2019-2025

Years
2019-2025
Top company
Actelion Pharmaceuticals US, INC.
Context
The $2,338 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/107782/zia-u-khan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.